Nicola Brunetti
Nicola Brunetti focuses his activity on private and public M&A, Capital Markets and Private Equity, advising major corporations, listed companies and private equity funds, in Italian and cross-border transactions. Nicola has also gained sound experience in advising multi-utility companies in their reorganization and consolidation process. Nicola is a founding partner of the firm and was a partner at Dewey & LeBoeuf and Simmons & Simmons.
He graduated in Law from the University of Pavia and was admitted to the Italian Bar Association in January 1996. From 1992 to 1995 Nicola collaborated with the department of civil law of the faculty of Economics of the University of Pavia.
He speaks Italian and English.
Gattai, Minoli, Partners in the new seed investment of Sofinnova Telethon in NanoPhoria
Gattai, Minoli, Partners advised Sofinnova Partners, leading European life sciences venture capital firm based in Paris, London and Milan, in the implementing, through its fund Sofinnova Telethon, a new seed investment in favour of NanoPhoria S.r.l., a pre-clinical stage biotech company that is developing a versatile, non-viral drug delivery platform based on inorganic nanoparticles.
Gattai, Minoli, Partners obtains the ISO 14064 "Carbon Footprint" certification for the Milan and Rome offices
Gattai, Minoli, Partners has successfully completed the process to obtain the ISO 14064 "Carbon Footprint" certification for its Milan and Rome offices.
Gattai, Minoli, Partners in Blackstone’s acquisition of a controlling stake in Reale Compagnia Italiana and subsequent takeover bid
Gattai, Minoli, Partners, with a multidisciplinary team coordinated by name partner Bruno Gattai and led by partner Andrea Francesco Castelli, advised Blackstone on all legal aspects related to the acquisition of the historic company based in Milan Reale Compagnia Italiana.
Gattai, Minoli, Partners in the acquisition of TAS by Gilde
Gattai, Minoli, Partners advised the management of TAS in the indirect sale of the share capital held by them in favour of the funds Gilde Buy-Out Fund VI and Gilde Buy-Out Fund VI 2, owned by Gilde Buyout Partners.
Gattai, Minoli, Partners with First Capital S.p.A. in the launch of the investment vehicle First4Progress
First Capital S.p.A., financial holding company specialized in Private Investments in Public and Private Equity, has launched, in collaboration with the consulting firm Capital For Progress Advisory, First4Progress S.p.A., an investment vehicle aiming at raising capitals for the growth of an Italian SME in the context of a pre-IPO or IPO transaction.
Gattai, Minoli, Partners and Fiera Milano for the 50th edition of Gastech
Gattai, Minoli, Partners advised Fiera Milano S.p.A. in the negotiations with DMG Events concerning the organization of the 50th edition of Gastech, the largest international event in the world dedicated to the energy industry, in particular the gas industry, which will be held in Milan in September 2022.
Gattai, Minoli, Partners advised Sofinnova Telethon in three new investments dedicated to Italian scientific research
Gattai, Minoli, Partners per gli aspetti corporate hanno assistito Sofinnova Partners, società leader in Europa nel settore delle scienze della vita e con sedi a Parigi, Londra e Milano, nell’implementazione di tre nuovi investimenti del fondo Sofinnova Telethon nelle start-up biotecnologiche AAVantgarde Bio, Alia Therapeuthics e Borea Therapeutics.
Gattai, Minoli, Partners legal advisor to CIR S.p.A. for the voluntary partial public tender offer on CIR’s ordinary shares
Gattai, Minoli, Partners, with Professor Piergaetano Marchetti, acted as legal counsel to CIR S.p.A. – Compagnie Industriali Riunite in the voluntary partial public tender offer launched for a maximum number of 156,862,745 ordinary shares, equal to 12.282% of the share capital of CIR.
Gattai, Minoli, Agostinelli & Partners with ReeVo for the IPO on AIM Italia
ReeVo S.p.A., an Italian cloud provider that has been offering Cloud, Cyber Security and Hybrid Cloud services for over 15 years, was granted admission to AIM Italia, a multilateral trading facility managed by Borsa Italiana.
Gattai Minoli Agostinelli & Partners in the entry of Roche Venture Fund in the capital of Enthera
Gattai Minoli Agostinelli & Partners assisted Enthera, biotech company that develops first-in-class biologics for several underserved autoimmune conditions in order to restore the regenerative capacity of stem cells, in the Series A investment for a total value of 35 million euros through the entry of Roche Venture Fund in the share capital.
Gattai, Minoli, Agostinelli & Partners in the Series A investment in Enthera S.r.l.
Gattai, Minoli, Agostinelli assisted Enthera S.r.l., for the contractual and corporate aspects, in the Euro 28 milion Series A Investment in Enthera S.r.l., a biotech company that develops first-in-class biologics for several underserved autoimmune conditions in order to restore the regenerative capacity of stem cells.
Gattai, Minoli, Agostinelli in the investment by Sofinnova Partners in GeneSpire and Epsilen Bio
Gattai, Minoli, Agostinelli advised Sofinnova Partners for the contractual and corporate aspects in the following investments.
Gattai, Minoli, Agostinelli & Partners legal advisor to MolMed S.p.A. in the public tender offer by AGC.
Gattai, Minoli, Agostinelli & Partners was legal advisor to MolMed S.p.A., a clinical stage biotechnology company focusing on research, development, manufacturing and clinical validation of cell & gene therapies for the treatment of cancer and rare diseases, in the voluntary public tender offer by AGC Inc. for 100% of the Company’s ordinary shares.
Gattai, Minoli, Agostinelli & Partners advisor to Fiera Milano in the acquisition of 60% of MADE Eventi
Gattai, Minoli, Agostinelli & Partners assisted Fiera Milano S.p.A. in the acquisition of 60% of MADE Eventi S.r.l., organizing company of MADE expo event, the biennial international exhibition of architecture and construction, owned by FederegnoArredo Eventi S.p.A.
Gattai, Minoli, Agostinelli & Partners legal Advisor to Credimi in the entry of two new investors into its share capital
Gattai, Minoli, Agostinelli & Partners advised Credimi S.p.A., an innovative fintech start-up, in the investment in the company’s share capital by United Ventures SGR S.p.A., an Italian independent venture capital management entity specialized in investments in innovative software and digital technologies companies, and Vertis SGR S.p.A., an independent asset management company active in private equity and venture capital funds management.
Gattai, Minoli, Agostinelli & Partners Advisor to CVC in the acquisition of a controlling stake in Recordati S.p.A.
Gattai Minoli Agostinelli & Partners assisted, on the M&A and the management re-investment aspects, the funds managed by CVC Capital Partners in the agreement for the acquisition of a controlling stake in Recordati S.p.A. from Recordati Family.
Gattai, Minoli, Agostinelli & Partners legal advisor to Capital for Progress 2 S.p.A. in the additional agreement with ABK
Gattai, Minoli, Agostinelli & Partners, with a team composed by Partner Nicola Brunetti, Of Counsel Emanuela Ciaffi and Associate Enrico Candotti, assisted Capital For Progress 2 S.p.A., the Special Purpose Acquisition Company listed on the AIM Market of the Italian stock exchange, in the additional agreement with ABK Group Industrie Ceramiche S.p.A., company manufacturer of ceramics and porcelain stoneware floor tiles.
Gattai, Minoli, Agostinelli & Partners: 21 lawyers ranked in “The Legal 500 2018”
“The Legal 500 2018” has been published. There are 21 lawyers ranked in 8 different practices confirming the experience and quality of the resources.
In particular, the international directory mentioned our law firm amongst the top 5 Italian law firms market players and reports that “Gattai has experienced impressive growth in recent years”.
Gattai, Minoli, Agostinelli & Partners legal advisor to Italmobiliare S.p.A. for the voluntary Partial Public Tender Offer on Italmobiliare’s ordinary shares
Gattai, Minoli, Agostinelli & Partners is legal advisor to Italmobiliare S.p.A. in the voluntary Partial Public Tender Offer, pursuant to articles 102 et seq. of the TUF on up to a maximum of n. 2,000,000 Italmobiliare ordinary shares, representing 8.4 % of the Italmobiliare share capital
Gattai, Minoli, Agostinelli & Partners appoints Nicola Brunetti as new office managing partner of the London office
Nicola Brunetti, is one of the Firm’s founding partners, specialized in M&A, Private Equity and Capital Markets dealing with both Italian and international clients.
Gattai, Minoli, Agostinelli & Partners legal advisor to di Banca Farmafactoring S.p.A. for the admission to trading of the Company’s ordinary shares on the MTA (Mercato Telematico Azionario) the online market segment organized and managed by Borsa Italiana
Gattai, Minoli, Agostinelli & Partners acted as legal advisor to Banca Farmafactoring for the admission to trading of the Company’s ordinary shares on the Mercato Telematico Azionario, organised and managed by Borsa Italiana S.p.A (MTA).
Gattai Minoli Agostinelli & Partners advisor of Index Ventures in the sale of Moleskine to D’Ieteren
Gattai, Minoli, Agostinelli & Partners assisted Index Ventures in the sale of a stake representing in aggregate 41% of Moleskine from Index Ventures and Syntegra Capital to D’Ieteren.
Gattai Minoli Agostinelli & Partners as legal advisors of Capital For Progress 1 Spa in the integration with GPI
Gattai Minoli Agostinelli & Partners advised Capital For Progress 1 SpA, a special purpose acquisition company (SPAC) listed on the Alternative Investment Market (AIM) Italy of Borsa Italiana, in the structuring of the transaction and in the negotiation of the agreements for the integration with GPI SpA.
Capital For Progress 1 lists itself on Borsa Italiana's AIM, the market for high-growth potential small and medium-sized companies
The investment company has today obtained the authorisation for admission from Borsa Italiana. The listing will concern ordinary shares for an exchange value equal to Euro 51.1 million with free warrants linked, to the extent of 2 warrants each 10 ordinary shares underwritten.
With Cerved Information Solutions SpA and CVC in the listing of ordinary shares on the screen-based stock exchange organised and managed by Borsa Italiana
Cerved Information Solutions S.p.A., Cerved Group's holding, has today filed the application for admission to the listing of its shares on Borsa Italiana.
With Jazz Pharmaceutical Plc in the acquisition of Gentium Spa
Gattai Minoli & Partners has assisted Jazz Pharmaceutical Plc, an Irish pharmaceutical company listed on Nasdaq, in the important acquisition of Italian company Gentium S.p.A., also listed on Nasdaq.